There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Vertex (VERX – Research Report) and AppLovin ...

Stifel Nicolaus analyst Brad Reback maintained a Hold rating on Vertex (VERX – Research Report) today and set a price target of $31.00. The ...

Equity markets started 2025 pretty well, but things haven't been so rosy in the past couple of months. The tech-heavy Nasdaq ...

Discover the best ways to bet on MLB spring training odds.

Most of the focus in generative AI has been on text-based interfaces used to generate text, images, and more. The next wave appears to be voice, and it’s ...

CRISPR Therapeutics' stock faces challenges with slow Casgevy adoption and competition. See how CRSP stock remains a cautious ...

URSC is built upon various shaders from the Godot community. It would not have been possible without the work done by: If you download URSC through the editor interface, uncheck "ignore asset root" to ...

Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic fibrosis treatment. Progress in that specialty area and two key drug approvals ...

Learn More › It seems ironic, but one of the most important things you can buy for your boat—which is made to take on the elements—is a boat cover to protect it from those same elements. The bottom ...

Here are the 55 best metal covers of classic rock hits. Playing covers, or even just riffs from your favorite songs is how so many musicians and bands start off. And even as careers progress and ...

Optum Rx, the pharmacy benefit manager owned by UnitedHealth Group, placed Journavx on some of its commercial formularies in ...